SCHEMBL6161355

SCHEMBL6161355

CCCOc1ccc(CNC(=O)c2c[nH]c3c(c2=O)CCC3)c(F)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 1/20 0.40
POLB P06746 1/20 0.40
KDM4E B2RXH2 3/20 0.39
CRBN Q96SW2 1/20 0.39
FFAR1 O14842 1/20 0.36
KAT6A Q92794 1/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
PDE4A P27815 1/20 0.35
PDE4B Q07343 1/20 0.35
PDE4C Q08493 1/20 0.35
PDE4D Q08499 1/20 0.35
HSD17B10 Q99714 2/20 0.35
ALDH1A1 P00352 1/20 0.35
MAPT P10636 1/20 0.35
HPGD P15428 1/20 0.35
TSHR P16473 1/20 0.35
MAPK1 P28482 1/20 0.35
LMNA P02545 1/20 0.35
MET P08581 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6161505 0.93 POLB (0.47) HTTPOLBKDM4EMEN1KMT2A
SCHEMBL6163159 0.91 POLB (0.47) HTTPOLBKDM4EMEN1KMT2A
SCHEMBL6162446 0.89 KDM4E (0.43) HTTKDM4EMEN1KMT2AHSD17B10
SCHEMBL6162486 0.87 PDE4A (0.39) POLBKDM4EPDE4APDE4BPDE4C
SCHEMBL6162568 0.87 LMNA (0.43) HTTPOLBKDM4EMEN1KMT2A
SCHEMBL6164858 0.85 PDE4A (0.39) POLBPDE4APDE4BPDE4CPDE4D
SCHEMBL6160973 0.79 GABRP (0.46) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL6162370 0.77 GABRP (0.46) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL6162060 0.77 POLB (0.54) POLBKDM4EMEN1KMT2AMAPT
SCHEMBL6161126 0.76 POLB (0.55) POLBKDM4EMEN1KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1056724-B1 SUBSTITUTED CYCLOALKYL-4-OXONICOTINIC CARBOXAMIDES; GABA BRAIN RECEPTOR LIGANDS NEUROGEN CORP (US) 2005-05-25 EP claimed
US-6448259-B1 CYCLOALKYL-4-OXONICOTINIC CARBOXAMIDES; AGONISTS, ANTAGONISTS OR INVERSE AGONISTS FOR GAMMA AMINOBUTYRIC ACID BINDING SITE, THE BENZODIAZEPINE RECEPTOR; ANXIETY, SLEEP AND SEIZURE DISORDERS SEDATIVE, ANXIOLYTIC AND ANTICONVULSANT ACTIVITY NEUROGEN CORPORATION 2002-09-10 US claimed
EP-1056724-B1 SUBSTITUTED CYCLOALKYL-4-OXONICOTINIC CARBOXAMIDES; GABA BRAIN RECEPTOR LIGANDS NEUROGEN CORP (US) 2005-05-25 EP disclosed
US-6448259-B1 CYCLOALKYL-4-OXONICOTINIC CARBOXAMIDES; AGONISTS, ANTAGONISTS OR INVERSE AGONISTS FOR GAMMA AMINOBUTYRIC ACID BINDING SITE, THE BENZODIAZEPINE RECEPTOR; ANXIETY, SLEEP AND SEIZURE DISORDERS SEDATIVE, ANXIOLYTIC AND ANTICONVULSANT ACTIVITY NEUROGEN CORPORATION 2002-09-10 US disclosed
US-6194427-B1 BRAIN DISORDERS; PSYCHOLOGICAL DISORDERS; SLEEP DISORDERS; ANTICONVULSANTS NEUROGEN CORPORATION 2001-02-27 US disclosed